Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.

Benzer Materyaller

• Acute reduction of TxA2 platelet binding sites after in vivo administration of a TxA2 receptor inhibitor.
  Yazar:: Modesti, P A, ve diğerleri
  Baskı/Yayın Bilgisi: (1991)
• Flavonoids inhibit the platelet TxA(2) signalling pathway and antagonize TxA(2) receptors (TP) in platelets and smooth muscle cells
  Yazar:: Guerrero, José A, ve diğerleri
  Baskı/Yayın Bilgisi: (2007)
• Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
  Yazar:: Lefer, A M, ve diğerleri
  Baskı/Yayın Bilgisi: (1980)
• Fatty acids and TxA(2) generation, in the absence of platelet-COX-1 activity
  Yazar:: DeFilippis, A.P., ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase.
  Yazar:: Hall, E R, ve diğerleri
  Baskı/Yayın Bilgisi: (1986)